Eli Lilly has launched Mounjaro (Tirzepatide) in India, being the first top pharma major to bring out a GLP-1/GIP dual-action weight-loss and diabetes drug into the country.
Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...
Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...
2d
Drug experts have revealed the two telltale signs that a weight loss jab bought online is fake - and could put you at risk of ...
US-based Lilly and Danish Novo Nordisk have seen skyrocketing global demand for their innovative weight-loss drugs, with ...
The following is a list of major prescription drugs whose ingredients or components are imported into the United States from the European Union, based on U.S. Food and Drug Administration import data ...
With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of ...
Snooker star Stuart Bingham has revealed that he has lost three stone after turning to fat-loss injections. The 2015 world ...
STUART BINGHAM admits he has shed three stone in weight after taking weekly fat-loss injections. The 2015 world snooker ...
"People come together, operators, with their supervisors at 6 a.m. every morning, and they talk about what issues they have and how they propose to solve it. Those get escalated through all levels of ...
I’m holding my Ozempic pen, a prefilled injection containing the active ingredient semaglutide ... Recent figures suggest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback